APOC2 and metabolic dysfunction-associated steatotic liver disease: It has been reported that APOC2 and APOC4proteins are decreased in patients with advanced fibrosis due to nonalcoholicfatty liver disease—aggravated NAFLD.46 Other apolipoproteins such as APOB (apolipoprotein B-100) also correlatewith liver disease in its aggravated stage.